Covered recipient · General Payments record
ANUM BHATIA
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2019
$435.21
- Reported across 10 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2019 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $310.21 | 9 |
By paying entity
PY2019 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $134.25 | 2 |
| Neurocrine BioSciences, Inc. | $87.64 | 1 |
| Alkermes, Inc. | $31.83 | 2 |
| Janssen Pharmaceuticals, Inc | $28.46 | 2 |
| Lundbeck LLC | $14.70 | 1 |
| Otsuka America Pharmaceutical, Inc. | $13.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2019 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $17.17 | 04/06/2019 | Food and Beverage | Undisputed | 01/23/2026 | 686575147 | CMS |
| Alkermes, Inc. | $14.66 | 06/14/2019 | Food and Beverage | Undisputed | 01/23/2026 | 686575149 | CMS |
| Janssen Pharmaceuticals, Inc | $14.54 | 04/04/2019 | Food and Beverage | Undisputed | 01/23/2026 | 658328374 | CMS |
| Janssen Pharmaceuticals, Inc | $13.92 | 05/31/2019 | Food and Beverage | Undisputed | 01/23/2026 | 658328517 | CMS |
| Lundbeck LLC | $14.70 | 05/16/2019 | Food and Beverage | Undisputed | 01/23/2026 | 684283015 | CMS |
| Neurocrine Biosciences, Inc. | $87.64 | 01/30/2019 | Food and Beverage | Undisputed | 01/23/2026 | 693115503 | CMS |
| Otsuka America Pharmaceutical, Inc. | $13.33 | 01/24/2019 | Food and Beverage | Undisputed | 01/23/2026 | 687354611 | CMS |
| Teva Pharmaceuticals USA, Inc. | $9.25 | 01/10/2019 | Food and Beverage | Undisputed | 01/23/2026 | 697679439 | CMS |
| Teva Pharmaceuticals USA, Inc. | $125.00 | 03/29/2019 | Food and Beverage | Undisputed | 01/23/2026 | 697875165 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019
- Source files
- Dataset page · Bulk file · PY2018 , PY2019
- Generated from
- OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.